Yiming Cheng

8PUBLICATIONS
12CO-AUTHORS
Stochastic analysis and modellingBiomolecular modelling and designHaematological tumoursMolecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 29, 2026
Partial Differential Equation (PDE)-Based Spatial Pharmacometrics in NONMEM: Method of Lines (MOL) Implementation with AI-Assisted Model Development.

|Apr 29, 2025
Model-informed Drug Development (MIDD) Approach to Support Biopharmaceutical Development of Iberdomide.

Caroline Sychterz, Ping Chen, Ajay Saxena

|Jan 21, 2025
Population Pharmacokinetics of Orvacabtagene Autoleucel, an Autologous BCMA-Directed Chimeric Antigen Receptor T-cell Product, in Patients with Relapsed/Refractory Multiple Myeloma.

Hongxiang Hu, Yan Li, Julia Piasecki

|Sep 03, 2024
Exposure-Response-Based Multiattribute Clinical Utility Score Framework to Facilitate Optimal Dose Selection for Oncology Drugs.

Yiming Cheng, Shuyu Chu, Jie Pu

|Mar 07, 2023
A Phase 1, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics of Iberdomide in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared with Healthy Subjects.

Yiming Cheng, Ying Ye, Allison Gaudy

|Sep 02, 2022
Aiding early clinical drug development by elucidation of the relationship between tumor growth inhibition and survival in relapsed/refractory multiple myeloma patients.

Yiming Cheng, Kevin Hong, Nianhang Chen

Pageof 2

Frequent Collaborators

1 joint publications

Shuyu Chu

1 joint publications

Paulo Maciag

1 joint publications

Li Zhu

1 joint publications

Yan Li